Company sees full-year COVID sales of $6 billion to $8 billion but says size of U.S. market is still uncertain
You are here: Home / Top Stories / : Moderna confirms COVID sales guidance as shares sink on Pfizer news
Market News and Views
Company sees full-year COVID sales of $6 billion to $8 billion but says size of U.S. market is still uncertain